Furthermore, it has been reported that SHMT2 is highly expressed in glioma, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma (12), reflecting that SHMT2 is partly involved in the process of tumorigenicity (10, 12, 13). The gene discussed is SHMT2; the disease is intrahepatic cholangiocarcinoma.